Tobinick; Edward Lewis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tobinick; Edward Lewis.The latest application filed is for "methods for treatment of brain injury utilizing biologics".

Company Profile

0.7.10

Tobinick; Edward Lewis - Boca Raton FL
Tobinick; Edward Lewis - Los Angeles CA US
Tobinick; Edward Lewis - Santa Monica CA
Tobinick; Edward Lewis - Los Angles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treatment of brain injury utilizing biologics Grant 9,808,523 - Tobinick November 7, 2	2017-11-07
Methods for treatment of brain injury utilizing biologics Grant 8,900,583 - Tobinick December 2, 2	2014-12-02
Methods for treatment of brain injury utilizing biologics App 20130224197 - Tobinick; Edward Lewis	2013-08-29
Methods To Facilitate Transmission Of Large Molecules Across The Blood-brain, Blood-eye, And Blood-nerve Barriers App 20130022540 - Tobinick; Edward Lewis	2013-01-24
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers Grant 8,236,306 - Tobinick August 7, 2	2012-08-07
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers App 20100129359 - Tobinick; Edward Lewis	2010-05-27
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers Grant 7,629,311 - Tobinick December 8, 2	2009-12-08
Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals App 20090130019 - Tobinick; Edward Lewis	2009-05-21
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers App 20070196375 - Tobinick; Edward Lewis	2007-08-23
Use and methods of use of etanercept and other TNF binding biologics to improve human cognitive function App 20060009450 - Tobinick; Edward Lewis	2006-01-12
Cytokine antagonists for neurological and neuropsychiatric disorders Grant 6,982,089 - Tobinick January 3, 2	2006-01-03
TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea App 20030113318 - Tobinick, Edward Lewis	2003-06-19
Cytokine antagonists for neurological and neuropsychiatric disorders App 20030049256 - Tobinick, Edward Lewis	2003-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.